Effect of more vs less frequent follow-up testing on overall and colorectal cancer-specific mortality in patients with stage II or III colorectal cancer: the COLOFOL randomized clinical trial.

Wille-Jørgensen, P; Syk, I; Smedh, K; Laurberg, S; Nielsen, D; Petersen, S; Renehan, Andrew G; Horváth-Puhó, E; Påhlman, L; Sørensen, H

dc.contributor.author	Wille-Jørgensen, P
dc.contributor.author	Syk, I
dc.contributor.author	Smedh, K
dc.contributor.author	Laurberg, S
dc.contributor.author	Nielsen, D
dc.contributor.author	Petersen, S
dc.contributor.author	Renehan, Andrew G
dc.contributor.author	Horváth-Puhó, E
dc.contributor.author	Påhlman, L
dc.contributor.author	Sørensen, H
dc.date.accessioned	2018-06-30T14:23:04Z
dc.date.available	2018-06-30T14:23:04Z
dc.date.issued	2018
dc.identifier.citation	Effect of more vs less frequent follow-up testing on overall and colorectal cancer-specific mortality in patients with stage II or III colorectal cancer: the COLOFOL randomized clinical trial. 2018, 319(20): 2095-2103 JAMA	en
dc.identifier.issn	1538-3598
dc.identifier.pmid	29800179
dc.identifier.doi	10.1001/jama.2018.5623
dc.identifier.uri	http://hdl.handle.net/10541/621085
dc.description.abstract	Intensive follow-up of patients after curative surgery for colorectal cancer is common in clinical practice, but evidence of a survival benefit is limited.
dc.language.iso	en	en
dc.rights	Archived with thanks to JAMA	en
dc.subject.mesh	Adult
dc.subject.mesh	Aftercare
dc.subject.mesh	Aged
dc.subject.mesh	Carcinoembryonic Antigen
dc.subject.mesh	Colorectal Neoplasms
dc.subject.mesh	Female
dc.subject.mesh	Follow-Up Studies
dc.subject.mesh	Humans
dc.subject.mesh	Intention to Treat Analysis
dc.subject.mesh	Male
dc.subject.mesh	Middle Aged
dc.subject.mesh	Mortality
dc.subject.mesh	Neoplasm Recurrence, Local
dc.subject.mesh	Neoplasm Staging
dc.subject.mesh	Proportional Hazards Models
dc.subject.mesh	Survival Rate
dc.subject.mesh	Time Factors
dc.subject.mesh	Tomography, X-Ray Computed
dc.title	Effect of more vs less frequent follow-up testing on overall and colorectal cancer-specific mortality in patients with stage II or III colorectal cancer: the COLOFOL randomized clinical trial.	en
dc.type	Article	en
dc.contributor.department	Abdominal Disease Center, Bispebjerg Hospital and Danish Colorectal Cancer Group, Copenhagen, Denmark	en
dc.identifier.journal	JAMA	en
refterms.dateFOA	2020-04-21T10:35:16Z
html.description.abstract	Intensive follow-up of patients after curative surgery for colorectal cancer is common in clinical practice, but evidence of a survival benefit is limited.